We conclude that the three molecules with the highest impact to the combined prognostic model show tumor anatomy- and patient-specific characteristics in their expression patterns with potentially complementary molecular events for CD68 and SMPD1 taking place in cells of the monocyte/macrophage lineage. This evidence concerns the gene SMPD1 and neoplasm.